|Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial|
RS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ...
The Lancet 387 (10027), 1540-1550, 2016
|Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study|
EEW Cohen, D Soulières, C Le Tourneau, J Dinis, L Licitra, MJ Ahn, ...
The Lancet 393 (10167), 156-167, 2019
|Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC)|
SM Gadgeel, NA Pennell, MJ Fidler, B Halmos, P Bonomi, J Stevenson, ...
Journal of Thoracic Oncology 13 (9), 1393-1399, 2018
|Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer|
JH Newman, CB Chesson, NL Herzog, PK Bommareddy, SM Aspromonte, ...
Proceedings of the National Academy of Sciences 117 (2), 1119-1128, 2020
|Esophageal carcinoma advances in treatment results for locally advanced disease|
A Herskovic, W Russell, M Liptay, MJ Fidler, M Al-Sarraf
Annals of oncology 23 (5), 1095-1103, 2012
|PTEN, RASSF1 and DAPK site‐specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients|
L Buckingham, L Penfield Faber, A Kim, M Liptay, C Barger, S Basu, ...
International journal of cancer 126 (7), 1630-1639, 2010
|Treatment of advanced squamous cell carcinoma of the lung: a review|
BA Derman, KF Mileham, PD Bonomi, M Batus, MJ Fidler
Translational lung cancer research 4 (5), 524, 2015
|Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial|
RS Herbst, P Baas, JL Perez-Gracia, E Felip, DW Kim, JY Han, JR Molina, ...
Annals of Oncology 30 (2), 281-289, 2019
|Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls|
MJ Fidler, DD Shersher, JA Borgia, P Bonomi
Therapeutic advances in medical oncology 4 (2), 51-60, 2012
|Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer|
BA Derman, JN Macklis, MS Azeem, S Sayidine, S Basu, M Batus, ...
BMC cancer 17, 1-6, 2017
|Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma|
DM Cognetti, JM Johnson, JM Curry, ST Kochuparambil, D McDonald, ...
Head & neck 43 (12), 3875-3887, 2021
|Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non‐small cell lung cancer in the National Cancer Data Base|
DJ Sher, M Koshy, MJ Liptay, MJ Fidler
Cancer 120 (13), 2060-2068, 2014
|The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non–small cell lung cancer patients treated with …|
MJ Fidler, A Argiris, JD Patel, DH Johnson, A Sandler, VM Villaflor, ...
Clinical cancer research 14 (7), 2088-2094, 2008
|Health-related quality of life in KEYNOTE-010: a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1 …|
F Barlesi, EB Garon, DW Kim, E Felip, JY Han, JH Kim, MJ Ahn, MJ Fidler, ...
Journal of Thoracic Oncology 14 (5), 793-801, 2019
|Cost-effectiveness analysis of chemoradiation therapy versus transoral robotic surgery for human papillomavirus–associated, clinical N2 oropharyngeal cancer|
DJ Sher, MJ Fidler, RB Tishler, K Stenson, S Al-Khudari
International Journal of Radiation Oncology* Biology* Physics 94 (3), 512-522, 2016
|Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients …|
MJ Edelman, MT Tan, MJ Fidler, RE Sanborn, G Otterson, LV Sequist, ...
Journal of Clinical Oncology 33 (2), 189, 2015
|Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer|
DJ Sher, MJ Fidler, MJ Liptay, M Koshy
Lung Cancer 88 (3), 267-274, 2015
|The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients|
MJ Fidler, CL Fhied, J Roder, S Basu, S Sayidine, I Fughhi, M Pool, ...
BMC cancer 18, 1-9, 2018
|Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparing|
V Dandekar, T Morgan, J Turian, MJ Fidler, J Showel, T Nielsen, ...
Oral oncology 50 (5), 520-526, 2014
|Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy|
S Garg, BT Gielda, K Kiel, JV Turian, MJ Fidler, M Batus, P Bonomi, ...
Practical radiation oncology 4 (5), 342-348, 2014